These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22452647)

  • 1. Clinical and pathological features of primary renal synovial sarcoma: analysis of 64 cases from 11 years of medical literature.
    Iacovelli R; Altavilla A; Ciardi A; Urbano F; Manai C; Gentile V; Cortesi E
    BJU Int; 2012 Nov; 110(10):1449-54. PubMed ID: 22452647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological features of primary neuroectodermal tumor/Ewing sarcoma of the kidney.
    Risi E; Iacovelli R; Altavilla A; Alesini D; Palazzo A; Mosillo C; Trenta P; Cortesi E
    Urology; 2013 Aug; 82(2):382-6. PubMed ID: 23800653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary synovial sarcoma of the kidney with rhabdoid features.
    Paláu L MA; Thu Pham T; Barnard N; Merino MJ
    Int J Surg Pathol; 2007 Oct; 15(4):421-8. PubMed ID: 17913954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension.
    Harb WJ; Luna MA; Patel SR; Ballo MT; Roberts DB; Sturgis EM
    Head Neck; 2007 Aug; 29(8):731-40. PubMed ID: 17274049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
    Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primitive renal synovial sarcoma: a cystic tumor in young patients].
    Long JA; Dinia EM; Saada-Sebag G; Cyprien J; Pasquier D; Thuillier C; Terrier N; Boillot B; Descotes JL; Rambeaud JJ
    Prog Urol; 2009 Jul; 19(7):474-8. PubMed ID: 19559377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
    Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
    Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
    Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
    Nilsson G; Skytting B; Xie Y; Brodin B; Perfekt R; Mandahl N; Lundeberg J; Uhlén M; Larsson O
    Cancer Res; 1999 Jul; 59(13):3180-4. PubMed ID: 10397263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma.
    Seidel C; Busch J; Weikert S; Steffens S; Fenner M; Ganser A; Grünwald V
    Eur J Cancer; 2012 May; 48(7):1023-30. PubMed ID: 22436979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.
    Cheville JC; Tindall D; Boelter C; Jenkins R; Lohse CM; Pankratz VS; Sebo TJ; Davis B; Blute ML
    Cancer; 2002 Sep; 95(5):1028-36. PubMed ID: 12209687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome.
    Okcu MF; Munsell M; Treuner J; Mattke A; Pappo A; Cain A; Ferrari A; Casanova M; Ozkan A; Raney B
    J Clin Oncol; 2003 Apr; 21(8):1602-11. PubMed ID: 12697886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
    Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
    BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal synovial sarcoma: a clinicopathological study of 6 cases.
    Chatzipantelis P; Kafiri G
    J BUON; 2008; 13(2):211-6. PubMed ID: 18555467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 expression is not associated with clinical outcome in synovial sarcoma.
    Carmody Soni EE; Miller BJ; Scarborough MT; Reith J; Gibbs CP
    Oncol Rep; 2011 Dec; 26(6):1513-7. PubMed ID: 21874258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
    Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Moon KC; Ku JH
    J Surg Oncol; 2007 Mar; 95(4):317-23. PubMed ID: 17066434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.